News from the healthcare data industry
The UK’s Association of the British Pharmaceutical Industry (ABPI) has recently concluded a consultation on its new draft industry governance principles aimed at guiding the pharmaceutical industry when analysing and using health...
BOSTON , April 4, 2022 /PRNewswire/ — Today, the Digital Medicine Society (DiMe), in partnership with Anthem, Biogen, Eli Lilly, Evidation, Janssen, Merck, Pfizer, and Savvy Co-op, announced the public launch of the 3Ps of...
NHS England is laying plans for the development of a federated data platform. It has published a prior information notice for potential suppliers, indicating that the procurement could have a total value...
Any company that depends upon data utilization knows that real-world data is challenging in terms of both cost and overall applicability: How synthetic data is increasingly coming to the rescue....
Posted 31 March 2022 | By Ferdous Al-Faruque While the US Food and Drug Administration (FDA) began the process of modernizing its IT systems before the COVID-19 pandemic, the crisis accelerated...
Zachary BrennanSenior EditorThe whole world watched in awe as the first two Covid-19 vaccines quickly made their way through clinical trials, offered stellar efficacy results and were quickly ushered across...
y Hettie Stroebel, Launch Excellence Regulatory approval usually requires definitive evidence from clinical trials. These are rooted in good study design, appropriate data collection, and thoughtful data analysis and may...
In 2019, Germany passed the Digital Healthcare Act, which, among other things, created a “Fast-Track” regulatory and reimbursement pathway for digital health applications in the German market. The pathway explicitly...
The agency’s accelerated approval program for certain drugs has come under intense scrutiny because some medicines stay on the market despite limited evidence that they work. Read more at the...
Abstract Aims: Using German claims, the authors replicated the CHAARTED trial in metastatic hormone-sensitive prostate cancer. Methods: The authors identified metastatic hormone-sensitive prostate cancer patients replicating the inclusion/exclusion criteria of CHAARTED. Patients treated...